Reaction Details |
| Report a problem with these data |
Target | Adenosine receptor A2a |
---|
Ligand | BDBM551572 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | Measurement of A2a Binding Affinity Using Radioligand Binding |
---|
IC50 | 51.6±n/a nM |
---|
Citation | Larsen, MA; Ali, A; Cumming, J; DeMong, D; Deng, Q; Graham, TH; Hennessy, E; Hoover, AJ; Liu, P; Liu, K; Mansoor, UF; Pan, J; Plummer, CW; Sather, A; Swaminathan, U; Wang, H; Zhang, Y 9-substituted amino triazolo quinazoline derivatives as adenosine receptor antagonists, pharmaceutical compositions and their use US Patent US11312719 Publication Date 4/26/2022 |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
Adenosine receptor A2a |
---|
Name: | Adenosine receptor A2a |
Synonyms: | A2A adenosine receptor (hA2A) | AA2AR_HUMAN | ADENOSINE A2 | ADENOSINE A2a | ADORA2 | ADORA2A | Adenosine A2A receptor (A2AAR) |
Type: | G Protein-Coupled Receptor (GPCR) |
Mol. Mass.: | 44716.46 |
Organism: | Homo sapiens (Human) |
Description: | P29274 |
Residue: | 412 |
Sequence: | MPIMGSSVYITVELAIAVLAILGNVLVCWAVWLNSNLQNVTNYFVVSLAAADIAVGVLAI
PFAITISTGFCAACHGCLFIACFVLVLTQSSIFSLLAIAIDRYIAIRIPLRYNGLVTGTR
AKGIIAICWVLSFAIGLTPMLGWNNCGQPKEGKNHSQGCGEGQVACLFEDVVPMNYMVYF
NFFACVLVPLLLMLGVYLRIFLAARRQLKQMESQPLPGERARSTLQKEVHAAKSLAIIVG
LFALCWLPLHIINCFTFFCPDCSHAPLWLMYLAIVLSHTNSVVNPFIYAYRIREFRQTFR
KIIRSHVLRQQEPFKAAGTSARVLAAHGSDGEQVSLRLNGHPPGVWANGSAPHPERRPNG
YALGLVSGGSAQESQGNTGLPDVELLSHELKGVCPEPPGLDDPLAQDGAGVS
|
|
|
BDBM551572 |
---|
n/a |
---|
Name | BDBM551572 |
Synonyms: | 1-(4-((2R or 2S,5R or 5S)-5-(5-amino-9-fluoro-7-methoxy- [1,2,4]triazolo[1,5-c]quinazolin-2-yl)-2-methylpiperidin-1- yl)-1H-pyrazol-1-yl)-2-methylpropan-2-ol | US11312719, Example 118 | US11312719, Example 119 | US11312719, Example 120 | US11312719, Example 121 |
Type | Small organic molecule |
Emp. Form. | C23H29FN8O2 |
Mol. Mass. | 468.5272 |
SMILES | COc1cc(F)cc2c3nc(nn3c(N)nc12)C1CCC(C)N(C1)c1cnn(CC(C)(C)O)c1 |
Structure |
|